The expanding family of regulatory B cells

International Immunology

Volumn 27, Issue 10, 2015, Pages 479-486

  Mauri, Claudia ^a   Menon, Madhvi ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

B cell; Bregs; Human; IL 10; Immune suppression; Mouse; Regulation; Regulatory B cells; Subsets

Indexed keywords

CD19 ANTIGEN; CD1D ANTIGEN; CD24 ANTIGEN; CD39 ANTIGEN; CD5 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; INTERLEUKIN 1; INTERLEUKIN 10; RITUXIMAB; STAT3 PROTEIN; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EXPERIMENTAL ALLERGIC ENCEPHALITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEMORY CELL; NONHUMAN; PLASMABLAST; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN PRESENTATION; CELL COMMUNICATION; CELL LINEAGE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; AUTOIMMUNE DISEASES; B-LYMPHOCYTES, REGULATORY; CELL COMMUNICATION; CELL LINEAGE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; INTERLEUKIN-10; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84945936980     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxv038     Document Type: Review

References (68)

1. Mauri, C. and Bosma, A. 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30:221.
2. Wolf, S. D., Dittel, B. N., Hardardottir, F. and Janeway, C. A. Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271.
3. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944.
4. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. and Bhan, A. K. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219.
5. Mauri, C., Gray, D., Mushtaq, N. and Londei, M. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197:489.
6. Carter, N. A., Rosser, E. C. and Mauri, C. 2012. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res. Ther. 14:R32.
7. Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A. et al. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178:7868.
8. Gray, M., Miles, K., Salter, D., Gray, D. and Savill, J. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl Acad. Sci. USA 104:14080.
9. Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M. and Tedder, T. F. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28:639.
10. O'Garra, A., Chang, R., Go, N., Hastings, R., Haughton, G. and Howard, M. 1992. Ly-1 B (B-1) cells are the main source of B cellderived interleukin 10. Eur. J. Immunol. 22:711.
11. Lundy, S. K. and Fox, D. A. 2009. Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. Arthritis Res. Ther. 11:R128.
12. Rafei, M., Hsieh, J., Zehntner, S. et al. 2009. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 15:1038.
13. Shen, P., Roch, T., Lampropoulou, V. et al. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507:366.
14. Matsumoto, M., Baba, A., Yokota, T. et al. 2014. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41:1040.
15. Ding, Q., Yeung, M., Camirand, G. et al. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121:3645.
16. Khan, A. R., Hams, E., Floudas, A., Sparwasser, T., Weaver, C. T. and Fallon, P. G. 2015. PD-L1hi B cells are critical regulators of humoral immunity. Nat. Commun. 6:5997.
17. Kaku, H., Cheng, K. F., Al-Abed, Y. and Rothstein, T. L. 2014. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. J. Immunol. 193:5904.
18. Blair, P. A., Chavez-Rueda, K. A., Evans, J. G. et al. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182:3492.
19. Schioppa, T., Moore, R., Thompson, R. G. et al. 2011. B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. Proc. Natl Acad. Sci. USA 108:10662.
20. Amu, S., Saunders, S. P., Kronenberg, M., Mangan, N. E., Atzberger, A. and Fallon, P. G. 2010. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125:1114.
21. Carter, N. A., Vasconcellos, R., Rosser, E. C. et al. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186:5569.
22. Sayi, A., Kohler, E., Toller, I. M. et al. 2011. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J. Immunol. 186:878.
23. Moreau, A., Blair, P. A., Chai, J. G. et al. 2015. Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival. Eur. J. Immunol. 45:843.
24. Srivastava, B., Lindsley, R. C., Nikbakht, N. and Allman, D. 2005. Models for peripheral B cell development and homeostasis. Semin. Immunol. 17:175.
25. Bankoti, R., Gupta, K., Levchenko, A. and Stäger, S. 2012. Marginal zone B cells regulate antigen-specific T cell responses during infection. J. Immunol. 188:3961.
26. Yanaba, K., Bouaziz, J. D., Matsushita, T., Tsubata, T. and Tedder, T. F. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182:7459.
27. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. and Tedder, T. F. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118:3420.
28. Yang, M., Deng, J., Liu, Y. et al. 2012. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am. J. Pathol. 180:2375.
29. Watanabe, R., Ishiura, N., Nakashima, H. et al. 2010. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 184:4801.
30. Yanaba, K., Yoshizaki, A., Asano, Y., Kadono, T., Tedder, T. F. and Sato, S. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178:735.
31. Yoshizaki, A., Miyagaki, T., DiLillo, D. J. et al. 2012. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491:264.
32. Kalampokis, I., Yoshizaki, A. and Tedder, T. F. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl. 1):S1.
33. Maseda, D., Smith, S. H., DiLillo, D. J. et al. 2012. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 188:1036.
34. Niedbala, W., Wei, X. Q., Cai, B. et al. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37:3021.
35. Collison, L. W., Workman, C. J., Kuo, T. T. et al. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566.
36. Wang, R. X., Yu, C. R., Dambuza, I. M. et al. 2014. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20:633.
37. Kuchroo, V. K., Dardalhon, V., Xiao, S. and Anderson, A. C. 2008. New roles for TIM family members in immune regulation. Nat. Rev. Immunol. 8:577.
38. Shalapour, S., Font-Burgada, J., Di Caro, G. et al. 2015. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521:94.
39. Liu, J., Zhan, W., Kim, C. J. et al. 2014. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses. PLoS One 9:e89236.
40. Shi, B. Y., Xiao, L., Gao, Y. et al. 2011. [Identification and functional study of Tim-1(+)CD19(+) regulatory B cell in kidney transplantation recipients]. Zhonghua Yi Xue Za Zhi 91:3388.
41. Xiao, S., Brooks, C. R., Zhu, C. et al. 2012. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc. Natl Acad. Sci. USA 109:12105.
42. Xiao, S., Brooks, C. R., Sobel, R. A. and Kuchroo, V. K. 2015. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J. Immunol. 194:1602.
43. Yeung, M. Y., Ding, Q., Brooks, C. R. et al. 2015. TIM-1 signaling is required for maintenance and induction of regulatory B cells. Am. J. Transplant. 15:942.
44. Hardy, R. R. 2006. B-1 B cell development. J. Immunol. 177:2749.
45. Zhang, X., Deriaud, E., Jiao, X., Braun, D., Leclerc, C. and Lo-Man, R. 2007. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J. Exp. Med. 204:1107.
46. Lundy, S. K. and Boros, D. L. 2002. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect. Immun. 70:812.
47. Shimomura, Y., Mizoguchi, E., Sugimoto, K. et al. 2008. Regulatory role of B-1 B cells in chronic colitis. Int. Immunol. 20:729.
48. Deaglio, S., Dwyer, K. M., Gao, W. et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:1257.
49. Correale, J., Farez, M. and Razzitte, G. 2008. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann. Neurol. 64:187.
50. Blair, P. A., Noreña, L. Y., Flores-Borja, F. et al. 2010. CD19(+) CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32:129.
51. Iwata, Y., Matsushita, T., Horikawa, M. et al. 2011. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530.
52. Lindner, S., Dahlke, K., Sontheimer, K. et al. 2013. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 73:2468.
53. van de Veen, W., Stanic, B., Yaman, G. et al. 2013. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J. Allergy Clin. Immunol. 131:1204.
54. Saze, Z., Schuler, P. J., Hong, C. S., Cheng, D., Jackson, E. K. and Whiteside, T. L. 2013. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 122:9.
55. Nouël, A., Pochard, P., Simon, Q. et al. 2015. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner. J. Autoimmun. 59:53.
56. Flores-Borja, F., Bosma, A., Ng, D. et al. 2013. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5:173ra23.
57. Bosma, A., Abdel-Gadir, A., Isenberg, D. A., Jury, E. C. and Mauri, C. 2012. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36:477.
58. Anolik, J. H., Barnard, J., Owen, T. et al. 2007. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 56:3044.
59. Palanichamy, A., Barnard, J., Zheng, B. et al. 2009. Novel human transitional B cell populations revealed by B cell depletion therapy. J. Immunol. 182:5982.
60. Siewe, B., Stapleton, J. T., Martinson, J. et al. 2013. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8? T cell function in vitro. J. Leukoc. Biol. 93:811.
61. Siewe, B., Wallace, J., Rygielski, S. et al. 2014. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One 9:e92934.
62. Nouël, A., Simon, Q., Jamin, C., Pers, J. O. and Hillion, S. 2014. Regulatory B cells: an exciting target for future therapeutics in transplantation. Front. Immunol. 5:11.
63. Khoder, A., Sarvaria, A., Alsuliman, A. et al. 2014. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood 124:2034.
64. Newell, K. A., Asare, A., Kirk, A. D. et al.; Immune Tolerance Network ST507 Study Group. 2010. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120:1836.
65. Cherukuri, A., Rothstein, D. M., Clark, B. et al. 2014. Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells. J. Am. Soc. Nephrol. 25:1575.
66. Shabir, S., Girdlestone, J., Briggs, D. et al. 2015. Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study. Am. J. Transplant. 15:1384.
67. Rosser, E. C., Oleinika, K., Tonon, S. et al. 2014. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat. Med. 20:1334.
68. Schubert, R. D., Hu, Y., Kumar, G. et al. 2015. IFN-β treatment requires B cells for efficacy in neuroautoimmunity. J. Immunol. 194:2110